COVID-19: JPT receives status as Systemically Important Company

Published on 01/06/2021

The current COVID-19 outbreak and the associated lockdown have had a huge impact on our daily routines leading to uncertainties and concerns.

We are pleased to announce that German authorities have confirmed JPT’s status as a Systemically Important Institution. Thus, JPT becomes part of relevant infrastructure, as we provide critical products to the global scientific community working on treatments, vaccines and diagnostic tests for SARS-CoV-2.

In order to maintain our current status JPT Peptide Technologies has implemented measures to minimize the impact and risks to current COVID-19 pandemic product manufacturing. For the safety of our staff, we

Enabled as many employees as possible to work from home.
Implemented working in shifts to ensure a secure distance can be maintained at all times for the operational staff.
Created procedures in our facilities to minimize contact between team members from different departments and to external visitors.
Installed additional hand sanitizers and implemented strict hygiene rules.

Please contact us at any time to receive an updated status of our manufacturing capacities or reserve a slot for your research or clinical grade COVID-19 peptide needs.

We hope you and your families stay safe and healthy!

Your JPT Team